ZIWIG
GynRAN is an international, multicentre, transversal, diagnostic and non-interventional study carried out in gynecology-obstetrics/gynecological oncology departments that aims to identify a diagnostic signature for gynecological pathologies by analyzing of coding and non-coding RNA contained in patients saliva. The study population consists of patients with clinically symptomatic females with one or more of the gynecological pathologies (endometriosis, adenomyosis, ovarian cysts, fibroids, ovarian/cervical/uterine cancer) and asymptomatic females. The patients concerned by the study will be managed without modification of the care pathway, nor modification of the therapeutic indications, nor modification of the diagnostic or follow-up examinations necessary according to the context, which are carried out according to the local recommendations.
Gynecologic Disease
Gynecologic Cancer
Endometriosis
Ovarian Cancer
Cyst Ovary
Fibroid
Cervical Cancer
Uterine Cancer
Saliva sample
Study Type : | Observational |
Estimated Enrollment : | 2500 participants |
Official Title : | Evaluation of Salivary RNA in Subjects Scheduled for Surgery for a Gynecologic Pathology |
Actual Study Start Date : | June 2024 |
Estimated Primary Completion Date : | June 2025 |
Estimated Study Completion Date : | June 2026 |
Information not available for Arms and Intervention/treatment
Ages Eligible for Study: | 18 Years |
Sexes Eligible for Study: | Female |
Accepts Healthy Volunteers: | Accepts Healthy Volunteers |
Want to participate in this study, select a site at your convenience, send yourself email to get contact details and prescreening steps.
Not yet recruiting
American Hospital of Paris
Neuilly-sur-Seine, France,